Specifications:: | 150mg*30 Capsules/bottle (box) | Indications: | Non-small Cell Lung Cancer, Inflammatory Myofibroblastic Tumor |
---|---|---|---|
Target: | ALK | Product Name: | Ceritinib/ceritinib |
Recommended Dose: | Please Follow Doctor's Advice | Storage: | Store Below 30℃ |
Highlight: | skins endocrine rheumatism treatment drugs,skins endocrine rheumatism treatment drugs,skin endocrine rheumatism treatment drugs |
Specifications | 150mg*30 capsules/bottle (box) |
---|---|
Indications | Non-small cell lung cancer, inflammatory myofibroblastic tumor |
Target | ALK |
Product Name | Ceritinib/ceritinib |
Recommended Dose | Please follow doctor's advice |
Storage | Store below 30℃ |
Ceritinib is indicated for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) and inflammatory myofibroblastic tumors.
Due to regulatory considerations, for additional information regarding ceritinib dosage, pricing, manufacturer details (including Novartis), and molecular structure, please contact us via WhatsApp: +8613313517590